Data / Medical devices / Japan / PHC Corporation
PHC Corporation: FDA-registered device maker in Chiyoda-ku Tokyo, Japan, 16 510(k) clearances and 2 PMA approvals
PHC Corporation is registered with the FDA (registration 3014353045) in Chiyoda-ku Tokyo, Japan. It lists 15 device types. The FDA files 16 510(k) clearances and 2 PMA approvals under its listings, the newest dated March 20, 2024. Registered through 2027. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3014353045
- Address
- 15F DAI-ICHI LIFE HIBIYA FIRST 1-13-2 Yurakucho, Chiyoda-ku Tokyo, Japan, 100-8403
- Owner or operator
- PHC Corporation (9052268)
- Roles
- Exporter to the US
- First device listed
- September 24, 2003
- Registered through
- 2027
- Brand names listed
- CONTOUR BLOOD GLUCOSE TEST STRIPS, CONTOUR NEXT ONE Blood Glucose Monitoring System, CONTOUR NEXT Test Strip, Contour Next EZ Blood Glucose Meter, Contour Next Link 2.4, Contour Next, Contour Next Link, Contour Next One, MCO-170MP, MCO-50M and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| March 20, 2024 | K231974 | PATHFAST®hs-cTnI-II | MMI | Substantially Equivalent | Phc Corporation | accessdata.fda.gov |
| November 8, 2019 | K191286 | CONTOUR® NEXT Blood Glucose Monitoring System, CONTOUR® NEXT USB Blood Glucose Monitoring System, CONTOUR® NEXT ONE Blood Glucose Monitoring System, CONTOUR® NEXT EZ Blood Glucose Monitoring System, CONTOUR® NEXT LINK Wireless Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care | accessdata.fda.gov |
| November 22, 2017 | K170983 | NIOX VERO | MXA | Substantially Equivalent | Circassia AB | accessdata.fda.gov |
| January 12, 2017 | K162336 | Contour Next EZ Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care U.S., Inc. | accessdata.fda.gov |
| November 17, 2016 | K160682 | CONTOUR NEXT ONE Blood Glucose Monitoring System | NBW | Substantially Equivalent | Ascensia Diabetes Care | accessdata.fda.gov |
| February 26, 2015 | K150233 | NIOX VERO Airway Inflammation Monitor | MXA | Substantially Equivalent | Aerocrine AB | accessdata.fda.gov |
| November 6, 2014 | K133898 | NIOX VERO AIRWAY INFLAMMATION MONITOR | MXA | Substantially Equivalent | Aerocrine AB | accessdata.fda.gov |
| June 23, 2014 | K130265 | CONTOUR NEXT EZ BLOOD GLUCOSE METER | NBW | Substantially Equivalent | Bayer Healthcare, LLC | accessdata.fda.gov |
| July 26, 2012 | K121190 | CONTOUR NEXT BLOOD GLUCOSE METER | LFR | Substantially Equivalent | Bayer Healthcare, LLC | accessdata.fda.gov |
| March 6, 2012 | K111268 | CONTOUR (R) NEXT BLOOD GLUCOSE MONITORING SYSTEM | LFR | Substantially Equivalent | Bayer Healthcare | accessdata.fda.gov |
| May 16, 2011 | K100130 | PATHFAST CTNI-II TEST, PATHFAST CTNI CALIBRATORS, PATHFAST SAMPLE DILUENT 2 | MMI | Substantially Equivalent | Mitsubishi Chemical Medience CO | accessdata.fda.gov |
| August 17, 2009 | K081360 | PATHFAST CK-MB-II, PATHFAST MYO-II | JHX | Substantially Equivalent | Mitsubishi Kagaku Iatron | accessdata.fda.gov |
| May 6, 2009 | K072288 | PATHFAST D-DIMER | GHH | Substantially Equivalent | Mitsubishi Kagaku Iatron | accessdata.fda.gov |
| March 9, 2009 | K083412 | PATHFAST HSCRP | DCN | Substantially Equivalent | Mitsubishi Kagaku Iatron | accessdata.fda.gov |
| February 5, 2008 | K072189 | PATHFAST NTPROBNP AND D-DIMER TESTS | NBC | Substantially Equivalent | Mitsubishi Kagaku Iatron | accessdata.fda.gov |
| September 11, 2006 | K062058 | ASCENSIA CONTOUR BLOOD GLUCOSE METER, MODEL 7151; REAGENT STRIP, MODEL 7080 | NBW | Substantially Equivalent | Bayer Healthcare | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| September 28, 2016 | P160017 | MiniMed 670G System | OZP | 126 | September 29, 2026 | accessdata.fda.gov |
| August 10, 2016 | P150001 | MINIMED 630G SYSTEM WITH SMARTGUARD(TM) | OZO | 100 | July 21, 2026 | accessdata.fda.gov |
Compare with other makers
- All makers of Glucose Dehydrogenase, Glucose
- All makers of System, Test, Blood Glucose, Over The Counter
- All makers of Automated Insulin Dosing , Threshold Suspend
- All makers of Test, Natriuretic Peptide
- All makers of System, Test, Breath Nitric Oxide
- All makers of System, Test, C-Reactive Protein
Updated September 29, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.